Omalizumab in patients with severe uncontrolled asthma: well-defined eligibility criteria to promote asthma control.

about

Omalizumab in patients with severe uncontrolled asthma: well-defined eligibility criteria to promote asthma control.

Item

http://www.wikidata.org/entity/Q49197103

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Omalizumab in patients with se ...... ria to promote asthma control.

@en

Omalizumab in patients with se ...... ria to promote asthma control.

@nl

type

Item

label

Omalizumab in patients with se ...... ria to promote asthma control.

@en

Omalizumab in patients with se ...... ria to promote asthma control.

@nl

prefLabel

Omalizumab in patients with se ...... ria to promote asthma control.

@en

Omalizumab in patients with se ...... ria to promote asthma control.

@nl

P1476

Omalizumab in patients with se ...... ria to promote asthma control.

@en

P2093

Alberto Cukier

http://www.w3.org/2001/XMLSchema#string

Rafael Stelmach

http://www.w3.org/2001/XMLSchema#string

Regina Maria de Carvalho-Pinto

http://www.w3.org/2001/XMLSchema#string

Rosana Câmara Agondi

http://www.w3.org/2001/XMLSchema#string

P2860

A workshop on asthma management programs and centers in Brazil: reviewing and explaining concepts.

Safety of anti-immunoglobulin E therapy with omalizumab in allergic patients at risk of geohelminth infection.

Can severe asthmatic patients achieve asthma control? A systematic approach in patients with difficult to control asthma followed in a specialized clinic.

Impact of omalizumab on treatment of severe allergic asthma in UK clinical practice: a UK multicentre observational study (the APEX II study).

Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair Registry.

Clinical characteristics and possible phenotypes of an adult severe asthma population.

Effect of omalizumab as add-on therapy on asthma-related quality of life in severe allergic asthma: a Brazilian study (QUALITX).

Precision Medicine. Personalizing Guidelines to the Provider as Well as the Patient: Making the Juice Worth the Squeeze.

Effects of weight loss on asthma control in obese patients with severe asthma.

Use of omalizumab in a severe asthma clinic.

P304

487-489

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1590/S1806-37562017000000012

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Pedro Giavina-Bianchi

P577

2017-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29340498

http://www.w3.org/2001/XMLSchema#string

P921

asthma

P932

5792049

http://www.w3.org/2001/XMLSchema#string